本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Travere Therapeutics, Inc.

21.96
+0.81003.83%
成交量:79.63万
成交额:1,707.53万
市值:19.50亿
市盈率:-7.91
高:22.07
开:21.05
低:20.85
收:21.15
数据加载中...
2021/05/06

重要事件披露

8-K - Current report
2021/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

重要事件披露

8-K - Current report
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

重要事件披露

8-K - Current report
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

重要事件披露

8-K - Current report
2021/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2021/01/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/18

重要事件披露

8-K - Current report
2020/11/18

重要事件披露

8-K/A [Amend] - Current report
2020/11/16

重要事件披露

8-K - Current report